GLP-2 compounds, formulations, and uses thereof

Details GLP-2 compounds, formulations, and uses thereof GLP-2 compounds, formulations, and uses thereof

2003-10-14

2008-08-12

Gupta, Anish (Department: 1654)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Glucagon; related peptides

C530S325000, C514S002600, C514S012200

Reexamination Certificate

active

07411039

ABSTRACT:
The present invention relates to novel human glucagon-like peptide-2 (GLP-2) peptides and human glucagon-like peptide-2 derivatives which have a protracted profile of action as well as polynucleotide constructs encoding such peptides, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.

REFERENCES:
patent: 5470582 (1995-11-01), Supersaxo et al.
patent: 5512549 (1996-04-01), Chen et al.
patent: 5624894 (1997-04-01), Bodor
patent: 5789379 (1998-08-01), Drucker et al.
patent: 5834428 (1998-11-01), Drucker
patent: 5869602 (1999-02-01), Jonassen et al.
patent: 5912229 (1999-06-01), Thim et al.
patent: 5952301 (1999-09-01), Drucker
patent: 5990077 (1999-11-01), Drucker
patent: 5994500 (1999-11-01), Drucker et al.
patent: 6051557 (2000-04-01), Drucker
patent: 6184201 (2001-02-01), Drucker et al.
patent: 6297214 (2001-10-01), Drucker
patent: 6489295 (2002-12-01), Drucker et al.
patent: 6586399 (2003-07-01), Drucker
patent: 2001/0016643 (2001-08-01), Jonassen et al.
patent: 2001/0021767 (2001-09-01), Drucker et al.
patent: 2001/0027180 (2001-10-01), Isaacs
patent: 2002/0025933 (2002-02-01), Knudsen et al.
patent: 2003/0040478 (2003-02-01), Drucker et al.
patent: 2003/0109449 (2003-06-01), Drucker et al.
patent: 2003/0158101 (2003-08-01), Drucker
patent: 2003/0162703 (2003-08-01), Drucker et al.
patent: 2004/0127418 (2004-07-01), Knudsen et al.
patent: 2137206 (1994-12-01), None
patent: 0891378 (1997-02-01), None
patent: WO 91/11457 (1991-08-01), None
patent: WO 95/07931 (1995-03-01), None
patent: 96/29342 (1996-09-01), None
patent: WO 96/32414 (1996-10-01), None
patent: WO 97/31943 (1997-09-01), None
patent: WO 97/39031 (1997-10-01), None
patent: WO 98/03547 (1998-01-01), None
patent: WO 98/03547 (1998-01-01), None
patent: 98/08871 (1998-03-01), None
patent: WO 98/08872 (1998-03-01), None
patent: WO 98/25644 (1998-06-01), None
patent: WO 98/52600 (1998-11-01), None
patent: WO 99/43361 (1999-09-01), None
patent: WO 99/58144 (1999-11-01), None
patent: WO 01/41779 (2001-06-01), None
patent: WO 01/49314 (2001-07-01), None
patent: WO 01/49314 (2001-07-01), None
patent: WO 0149314 (2001-07-01), None
patent: WO 0149314 (2001-07-01), None
patent: 02/066511 (2002-08-01), None
patent: 02/066511 (2002-08-01), None
patent: WO 02/066062 (2002-08-01), None
patent: WO 02/066062 (2002-08-01), None
Clodfelter et al., Pharmaceutical Res. 15(2):254-262 (1998).
Shennan et al., Molecular and Cellular Endocrinology: vol. 67; pp. 93-99 (1989).
Watanabe et al., Biochem and Biophys Res. Com, vol. 152 (3); pp. 1038-1044 (May 16, 1988).
Lund et al., Digestion; pp. 371-373 (Nov.-Dec. 1993).
Orskov et al., Diabetologia, vol. 30; pp. 874-881 (1987).
Orskov et al., FEBS Letters, vol. 247 (2); pp. 193-196 (Apr. 1989).
George et al., FEBS Letters, vol. 192 (2); pp. 275-278 (1985).
Hoosein et al., FEBS Letters, vol. 178 (1); pp. 83-86 (Dec. 1984).
Buhl et al., Journ of Biol Chem, vol. 263 (18); pp. 8621-8624 (Jun. 25, 1998).
Lee et al., Journ of Biol Chem, vol. 267 (15); pp. 10705-10708 (May 1992).
Orskov et al., Scand J. Clin. Lab. Invest, vol. 47 (2); pp. 165-174 (Apr. 1987).
Barragan et al., Am. J. of Physiol, vol. 266 (3 Part 1); pp. E459-E466 (Mar. 1994).
Brubaker et al., Endocrin., vol. 128 (6); pp. 3175-3182 (1991).
Calvo et al., J. Neurochem, vol. 64 (1); pp. 299-306 (Jan. 1995).
Drucker, Pancreas, vol. 5 (4); pp. 484-488 (1990).
Mojsov et al., Journ of Biol. Chem., vol. 261 (25); pp. 11880-11889 (Sep. 5, 1986).
Orskov et al., Endocrin., vol. 119 (4); pp. 1467-1475 (1986).
Madsen et al., Endocrin., vol. 133 (5); pp. 2022-2030 (1993).
Siegel et al., Reg. Peptides, vol. 79; pp. 93-102 (1999).
Gallwitz et al., Reg. Peptides, vol. 86; pp. 103-111 (2000).
Turton et al., Nature, vol. 379; pp. 69-71 (1996).
Flint et al., J. Clin. Invest., vol. 101 (3); pp. 515-520 (1998).
Gutzwiller et al., Gut, vol. 44; pp. 81-86 (1999).
Naslund et al., Int. J. of Obesity, vol. 23; pp. 304-311 (1999).
Sorensen et al., Int. J. of Obesity., vol. 27; pp. 450-456 (2003).
Drucker et al., J. Nature Biotech, vol. 15; pp. 673-677 (1997).
Nishi et al., Mol. Endocrin., vol. 4; pp. 1192-1198 (1990).
Mentlein et al., Eur. J. Biochem., vol. 214; pp. 829-835 (1993).
Peninsula Laboratories, Inc. Catalog 1993-1994.
Demuth et al., Dipeptidy Peptidase IV (CD26) in Metab. Immune Resp., Chptr 1, pp. 1-35 (Springer, RG Landis Co. Austin TX) (1995).
Bongers et al., Biochim et Biophys. Acta, vol. 1122; pp. 147-153 (1992).
Gallwitz et al., Eur. J. Biochem, vol. 225; pp. 1151-1156 (1994).
Deacon et al., Diabetes, vol. 44; pp. 1126-1131 (1995).
Kieffer et al., Endocrin., vol. 136 (8); pp. 3585-3596 (1995).
Drucker et al., Proc. Natl. Acad. Sci. USA, vol. 93; pp. 7911-7916 (1996).
Drucker et al., , Intestinal Growth Factors; pp. G1252-G1262.
U.S. Appl. No. 08/631,273, filed Apr. 12, 1996, Drucker et al.
Lund et al., Digestion., vol. 46 (suppl. 2); pp. 66-73 (1990).
Ehrlich et al., Reg. of Proglucagon Gene Express.; pp. E662-E671.
Orskov et al., Abstract P6.
Tang-Christiansen et al., Nature Medicine, vol. 6 (7), pp. 802-807 (Jul. 2000).
Substantive Arguments to Date from Opposition to European Patent 0 891 378.
Drucker et al., Proc. Natl. Acad. Sci. USA, vol. 93, pp. 7911-7916 (1996).

Affiliated with

Also associated with

Rating

GLP-2 compounds, formulations, and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GLP-2 compounds, formulations, and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GLP-2 compounds, formulations, and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4013566